Ohio Administrative Code Search
| Rule |
|---|
|
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state... |
|
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an a... |
|
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
...A licensee may use any unsealed radioactive material prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive drug producer licensed in accordance with paragraph (I) o... |
|
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
...A licensee may use any unsealed radioactive material identified in paragraph (B)(1)(b)(vi) of rule 3701:1-58-40 the Administrative Code prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state ... |
|
Rule 3701:1-58-38 | Safety instruction for unsealed radioactive material.
...In addition to the requirements of rule 3701:1-38-10 of the Administrative Code, (A) A licensee shall provide radiation safety instruction, initially and at least annually, to personnel caring for patients or human research subjects who cannot be released under rule 3701:1-58-30 of the Administrative Code. To satisfy this requirement, the instruction must be commensurate with the duties of the personnel and include:... |
|
Rule 3701:1-58-39 | Safety precautions for unsealed radioactive material.
...(A) For each patient or human research subject who cannot be released under rule 3701:1-58-30 of the Administrative Code, a licensee shall: (1) Quarter the patient or the human research subject either in: (a) A private room with a private sanitary facility; or (b) A room, with a private sanitary facility, with another individual who also has received therapy with unsealed radioactive material and who also cannot b... |
|
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement st... |
|
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
|
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
|
Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in par... |
|
Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the require... |
|
Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in paragraphs (... |
|
Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in ... |
|
Rule 3701:1-58-43 | Use of sources for manual brachytherapy.
...A licensee shall use only brachytherapy sources for therapeutic medical uses: (A) As approved in the sealed source and device registry; or (B) In research in accordance with an active investigational device exemption application accepted by the United States food and drug administration provided the requirements of rule 3701:1-58-17 of the Administrative Code are met. |
|
Rule 3701:1-58-43 | Use of sources for manual brachytherapy.
...A licensee shall use only brachytherapy sources: (A) As approved in the sealed source and device registry for manual brachytherapy medical use. The manual brachytherapy sources may be used for manual brachytherapy uses that are not explicitly listed in the sealed source and device registry, but must be used in accordance with the radiation safety conditions and limitations described in the sealed s... |
|
Rule 3701:1-58-44 | Surveys after source implant and removal.
...(A) The licensee shall make a survey to locate and account for all sources that have not been implanted immediately after implanting sources in a patient or a human research subject. (B) The licensee shall make a survey of the patient or the human research subject with a radiation detection survey instrument to confirm that all sources have been removed immediately after removing the last temporary implant source fr... |
|
Rule 3701:1-58-45 | Brachytherapy sources accountability.
...(A) A licensee shall maintain accountability at all times for all brachytherapy sources in storage or use. (B) As soon as possible after removing sources from a patient or a human research subject, a licensee shall return brachytherapy sources to a secure storage area. (C) A licensee shall maintain a record of the brachytherapy source accountability in accordance with rule 3701:1-58-88 of the Administrative Code. |
|
Rule 3701:1-58-46 | Safety instruction for manual brachytherapy.
...In addition to the requirements of rule 3701:1-38-10 of the Administrative Code: (A) The licensee shall provide radiation safety instruction, initially and at least annually, to personnel caring for patients or human research subjects who are receiving brachytherapy and cannot be released under rule 3701:1-58-30 of the Administrative Code. To satisfy this requirement, the instruction must be commensurate with the du... |
|
Rule 3701:1-58-47 | Safety precautions for manual brachytherapy.
...(A) For each patient or human research subject who is receiving brachytherapy and cannot be released under rule 3701:1-58-30 of the Administrative Code, a licensee shall: (1) Not quarter the patient or the human research subject in the same room as an individual who is not receiving brachytherapy; (2) Visibly post the patient's or human research subject's room with a "radioactive materials" sign; and (3) Note on t... |
|
Rule 3701:1-58-48 | Calibration measurements of brachytherapy sources.
...(A) Before the first medical use of a brachytherapy source, a licensee shall have: (1) Determined the source output or activity using a dosimetry system that meets the requirements of paragraph (A) of rule 3701:1-58-60 of the Administrative Code; (2) Determined source positioning accuracy within applicators; and (3) Used published protocols currently accepted by nationally recognized bodies to meet the requirement... |
|
Rule 3701:1-58-49 | Decay of strontium-90 sources for ophthalmic treatments.
...(A) Only an authorized medical physicist shall calculate the activity of each strontium-90 source that is used to determine the treatment times for ophthalmic treatments. The decay must be based on the activity determined under rule 3701:1-58-48 of the Administrative Code. (B) A licensee shall retain a record of the activity of each strontium-90 source in accordance with rule 3701:1-58-90 of the Administrative Code... |
|
Rule 3701:1-58-49 | Strontium-90 sources for ophthalmic treatments.
...(A) Licensees who use strontium-90 for ophthalmic treatments must ensure that certain activities as specified in paragraph (B) of this rule are performed by either: (1) An authorized medical physicist; or (2) An individual who: (a) Is identified as an ophthalmic physicist on a specific medical use license issued by the director, United States nuclear regulatory commission or an agreement state; per... |
|
Rule 3701:1-58-51 | Training for use of manual brachytherapy sources.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of a manual brachytherapy source for the uses authorized under rule 3701:1-58-43 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement st... |
|
Rule 3701:1-58-51 | Training for use of manual brachytherapy sources.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of a manual brachytherapy source for the uses authorized under rule 3701:1-58-43 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, the United States nuclear regulatory commission, ... |
|
Rule 3701:1-58-51 | Training for use of manual brachytherapy sources.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of a manual brachytherapy source for the uses authorized under rule 3701:1-58-43 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, the United States nuclear regulatory commission, ... |